加州52,599例甲状腺癌分析:初始诊疗与医院手术量的差异
研究纳入1999至2017年加州52,599例接受甲状腺切除术的甲状腺癌患者,按医院年手术量中位数分组。在年手术量≤5例的超低量中心手术者,因复发/持续病灶再次手术的几率高于低、中、高量中心,接受符合指南的131I消融的几率更低;超低量中心服务更多女性和社会经济弱势人群。
要点
- 超低量中心(≤5例/年)再次手术风险高于低量中心(OR 1.17)、中量中心(OR 1.25)和高量中心(OR 1.26)。
- 超低量中心患者接受符合指南的131I消融几率低于更高量中心(OR 0.77 [CI 0.72-0.82])。
- 低、中、高量中心之间所有结局的配对比较均无统计学显著差异。
核心结论
- 在年手术量≤5例的中心接受甲状腺癌手术的患者,因复发/持续病灶需再次手术的几率更高,接受适当131I消融的几率更低;超低量中心服务的社会和经济边缘化人群比例更高。
研究设计与样本
- 研究查询了加州癌症登记处与加州州立健康规划与发展办公室的关联数据库,纳入1999至2017年接受甲状腺手术的甲状腺癌患者。
- 医院按甲状腺癌手术年手术量中位数分层:超低量(0-5例/年)、低量(6-25例/年)、中量(26-50例/年)和高量(>50例/年)。
- 研究分析了并发症发生率、因癌症复发再次手术率、放射性碘(131I)使用率和死亡率,并用多变量回归控制高风险肿瘤特征。
- 样本量为52,599例甲状腺癌患者。
主要发现
- 在超低量中心手术者因复发/持续病灶再次手术的几率高于低量中心(OR 1.17 [CI 1.02-1.35])、中量中心(OR 1.25 [CI 1.06-1.46])和高量中心(OR 1.26 [CI 1.03-1.56])。
- 在超低量中心手术者接受符合指南的131I消融的几率低于更高量中心(OR 0.77 [CI 0.72-0.82])。
- 所有结局在各手术量类别间的配对比较显示,低量、中量和高量中心之间的结局无统计学显著差异;仅超低量中心的不良结局发生率显著更高。
- 与更高量中心相比,超低量中心不成比例地服务女性(p < 0.05)、西班牙裔、亚裔/太平洋岛民和美洲印第安人(p < 0.01)、社会经济地位最低三个五分位者(p < 0.01)以及无保险者和Medicaid或Medicare参保者(p < 0.01)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Racially minoritized patients with thyroid cancer are less likely to receive high-quality and guideline-concordant care. Inaccessibility of high-volume centers may contribute to inequalities in thyroid cancer outcomes. This study sought to understand the extent to which access to higher volume thyroid cancer centers is associated with patient outcomes. Methods: We queried linked California Cancer Registry and California Office of Statewide Health Planning and Development databases for thyroid cancer patients who received thyroid surgery between 1999 and 2017. Hospitals were stratified by their median annual volume of thyroid cancer operations: ultra-low volume (0-5 cases/year), low-volume (6-25 cases/year), mid-volume (26-50 cases/year), and high-volume (>50 cases/year). We analyzed the rates of complications, rates of reoperation for cancer recurrence, use of radioactive iodine (131I), and mortality by median hospital volume of thyroid surgery. A multivariable regression controlled for high-risk tumor features. Differences in access by center volume were assessed based on patient demographics. Results: We studied 52,599 thyroid cancer patients who underwent thyroidectomy. Patients who underwent thyroidectomy at ultra-low volume centers were more likely to undergo reoperations for recurrent/persistent disease compared with patients at low- (odds ratio [OR] 1.17 [CI 1.02-1.35]), mid- (OR 1.25 [CI 1.06-1.46]), and high-volume centers (OR 1.26 [CI 1.03-1.56]). Patients who received thyroid operations at ultra-low volume centers were also less likely to receive guideline-concordant 131I ablation compared with patients at higher volume centers (OR 0.77 [CI 0.72-0.82]). A pair-wise comparison between all volume categories for all outcomes revealed no statistically significant differences in outcomes between low-, mid-, or high-volume centers. Only ultra-low volume centers had significantly higher rates of adverse outcomes. Ultra-low volume centers were disproportionately accessed by women (p < 0.05), Hispanic, Asian/Pacific Islander, and American Indian people (p < 0.01), those from the lowest three quintiles of socio-economic status (p < 0.01), and the uninsured and those on Medicaid or Medicare (p < 0.01) when compared with higher volume centers. Conclusions: Patients receiving thyroid cancer surgery at centers performing ≤5 such operations per year were more likely to require reoperation for recurrent/persistent disease and less likely to receive appropriate 131I ablation. Ultra-low volume centers served higher proportions of socially and economically marginalized communities.
引用
- Huston-Paterson H, Mao Y, Tseng CH, et al. Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California. Thyroid. 2023. PMID: 37498775. doi:10.1089/thy.2023.0241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。